Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bristol-Myers Squibb divulges nonstructural protein 5B inhibitors

Sep. 7, 2016

SciFluor Life Sciences presents integrin beta-6/8 antagonists

Sep. 7, 2016

University of Southern California team reveals growth hormone receptor antagonists

Sep. 6, 2016

Agents for RSV infections described in Aviragen Therapeutics patent

Sep. 6, 2016

Lilly prepares and tests MetAP 2 and DPP IV inhibitors

Sep. 6, 2016

NEONC Technologies patent reports agents for treatment of cancer

Sep. 6, 2016

Latvian Institute of Organic Synthesis patents LeuRS inhibitors

Sep. 6, 2016

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical generate anti-HER2 antibody-drug conjugate

Sep. 5, 2016

Guangzhou Institutes of Biomedicine and Health divulges UCP 1 activators

Sep. 5, 2016

Shanghai De Novo Pharmatech identifies novel IDO1/TDO2 inhibitors

Sep. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...